Page last updated: 2024-08-25

almagate and Neoplasms

almagate has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, JS; Lü, YH; Wang, QZ; Yang, HY; Zhu, Y1
Becker, RC; Nimjee, SM; Sullenger, BA; White, RR1
Cavalli, M; Gatto, B1

Reviews

2 review(s) available for almagate and Neoplasms

ArticleYear
[Recent progress of the aptamer-based antiviral drugs].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:4

    Topics: Antiviral Agents; Aptamers, Nucleotide; Genome, Viral; Hepacivirus; HIV; HIV Reverse Transcriptase; Humans; Macular Degeneration; Neoplasms; Oligodeoxyribonucleotides; RNA, Small Interfering; SELEX Aptamer Technique; Viral Envelope Proteins; Virus Replication

2013
Aptamers as Therapeutics.
    Annual review of pharmacology and toxicology, 2017, 01-06, Volume: 57

    Topics: Animals; Aptamers, Nucleotide; Humans; Neoplasms; Randomized Controlled Trials as Topic; SELEX Aptamer Technique; Vision Disorders

2017

Other Studies

1 other study(ies) available for almagate and Neoplasms

ArticleYear
From proteins to nucleic acid-based drugs: the role of biotech in anti-VEGF therapy.
    Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Protein Engineering; Ranibizumab; RNA, Small Interfering; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors

2006